{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:49:39Z","timestamp":1794005379843,"version":"4.8.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biopha.2025.118076","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T03:16:49Z","timestamp":1745291809000},"page":"118076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Quinine-chalcone hybrids as potent inhibitors of P-glycoprotein with apoptotic effects on EBC-1 cells"],"prefix":"10.1016","volume":"187","author":[{"given":"Ang\u00e9la","family":"Tak\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5929-0064","authenticated-orcid":false,"given":"Malin","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-4646","authenticated-orcid":false,"given":"Eszter","family":"Lajk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3110-0379","authenticated-orcid":false,"given":"Zs\u00f3fia","family":"Sz\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5162-154X","authenticated-orcid":false,"given":"M\u00e1rton","family":"Kalabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antal","family":"Cs\u00e1mpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"K\u0151hidai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2025.118076_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081021","article-title":"Anti-cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: a review","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.biopha.2025.118076_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7915.2010.00221.x","article-title":"Natural products for cancer chemotherapy","volume":"4","author":"Demain","year":"2011","journal-title":"Micro Biotechnol."},{"issue":"42","key":"10.1016\/j.biopha.2025.118076_bib3","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1021\/ja9823870","article-title":"Solid and solution phase synthesis and biological evaluation of combinatorial sarcodictyin libraries","volume":"120","author":"Nicolaou","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2025.118076_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chroma.2018.04.038","article-title":"Quantitative determination of major alkaloids in Cinchona bark by Supercritical Fluid Chromatography","volume":"1554","author":"Murauer","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.biopha.2025.118076_bib5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria","volume":"10","author":"Achan","year":"2011","journal-title":"Malar. J."},{"issue":"9","key":"10.1016\/j.biopha.2025.118076_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/biology10090849","article-title":"Vincristine in combination therapy of cancer: emerging trends in clinics","volume":"10","author":"\u0160kubn\u00edk","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.biopha.2025.118076_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172472","article-title":"Alkaloids for cancer prevention and therapy: current progress and future perspectives","volume":"858","author":"Mondal","year":"2019","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118076_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13046-017-0502-8","article-title":"Cinchonine induces apoptosis of HeLa and A549 cells through targeting TRAF6","volume":"36","author":"Qi","year":"2017","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"6","key":"10.1016\/j.biopha.2025.118076_bib9","first-page":"5046","article-title":"Cinchonine activates endoplasmic reticulum stress-induced apoptosis in human liver cancer cells","volume":"15","author":"Jin","year":"2018","journal-title":"Exp. Ther. Med"},{"issue":"5-6","key":"10.1016\/j.biopha.2025.118076_bib10","first-page":"458","article-title":"Induction of apoptosis by alkaloids, non-protein amino acids, and cardiac glycosides in human promyelotic HL-60 cells","volume":"62","author":"Rosenkranz","year":"2007","journal-title":"Z. Nat. C. J. Biosci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118076_bib11","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/cbdd.13346","article-title":"Cytotoxic and trypanocidal activities of cinchona alkaloid derivatives","volume":"92","author":"Kacprzak","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"issue":"4","key":"10.1016\/j.biopha.2025.118076_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2025.118076_bib13","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/09168451.2018.1559030","article-title":"In vitro and in vivo cancer cell apoptosis triggered by competitive binding of Cinchona alkaloids to the RING domain of TRAF6","volume":"83","author":"Qi","year":"2019","journal-title":"Biosci. Biotechnol. Biochem"},{"issue":"3","key":"10.1016\/j.biopha.2025.118076_bib14","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3892\/mmr.2016.5492","article-title":"Suppression of tumor cell proliferation by quinine via the inhibition of the tumor necrosis factor receptor\u2011associated factor 6\u2011AKT interaction","volume":"14","author":"Liu","year":"2016","journal-title":"Mol. Med Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118076_bib15","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695966","article-title":"N6-Isopentenyladenosine promoted HeLa cell apoptosis through inhibitions of AKT and transforming growth factor \u03b2-activated kinase 1 activation","volume":"39","author":"Li","year":"2017","journal-title":"Tumour Biol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118076_bib16","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/cdd.2014.123","article-title":"TAK1 control of cell death","volume":"21","author":"Mihaly","year":"2014","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.biopha.2025.118076_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.294","article-title":"TAK1 regulates caspase 8 activation and necroptotic signaling via multiple cell death checkpoints","volume":"7","author":"Guo","year":"2016","journal-title":"Cell Death Dis."},{"issue":"6418","key":"10.1016\/j.biopha.2025.118076_bib18","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.aau2818","article-title":"Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death","volume":"362","author":"Orning","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.biopha.2025.118076_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12929-015-0182-7","article-title":"TAK1 inhibition-induced RIP1-dependent apoptosis in murine macrophages relies on constitutive TNF-\u03b1 signaling and ROS production","volume":"22","author":"Wang","year":"2015","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118076_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","article-title":"The role of cellular reactive oxygen species in cancer chemotherapy","volume":"37","author":"Yang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2025.118076_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41419-024-06939-5","article-title":"Oxidative cell death in cancer: mechanisms and therapeutic opportunities","volume":"15","author":"An","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118076_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102754","article-title":"Drug-induced oxidative stress in cancer treatments: angel or devil?","volume":"63","author":"Jiang","year":"2023","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118076_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.molmed.2017.03.004","article-title":"ROS in cancer: the burning question","volume":"23","author":"Chio","year":"2017","journal-title":"Trends Mol. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.118076_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1534735404270335","article-title":"Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness","volume":"3","author":"Conklin","year":"2004","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.biopha.2025.118076_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4615-4811-9_5","article-title":"Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP), Updated results of a randomized study. Groupe Fran\u00e7ais des My\u00e9lodysplasies (GFM) and Groupe GOELAMS","volume":"457","author":"Wattel","year":"1999","journal-title":"Adv. Exp. Med Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118076_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood.V77.2.348.348","article-title":"Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model","volume":"77","author":"Lehnert","year":"1991","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biopha.2025.118076_bib27","first-page":"2797","article-title":"Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo","volume":"52","author":"Genne","year":"1992","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.118076_bib28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00001813-199802000-00004","article-title":"A phase I\/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant disease","volume":"9","author":"Miller","year":"1998","journal-title":"Anticancer Drugs"},{"issue":"3","key":"10.1016\/j.biopha.2025.118076_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/bjc.1990.305","article-title":"Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice","volume":"62","author":"Chauffert","year":"1990","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118076_bib30","series-title":"Studies in Natural Products Chemistry","first-page":"269","article-title":"Chapter 8 - Plant Polyphenols: Recent Advances in Epidemiological Research and Other Studies on Cancer Prevention, in","author":"Valavanidis","year":"2013"},{"issue":"10","key":"10.1016\/j.biopha.2025.118076_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e20428","article-title":"Antiviral and antimicrobial applications of chalcones and their derivatives: From nature to greener synthesis","volume":"9","author":"Nematollahi","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2025.118076_bib32","unstructured":"Adam, M. and R. Cecilia, Chalcones: Potential Anticancer Agents, in Translational Research in Cancer, S. Sivapatham and G. Yeun-Hwa, Editors. 2021, IntechOpen: Rijeka. p. Ch. 5."},{"issue":"6","key":"10.1016\/j.biopha.2025.118076_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060894","article-title":"Chalcone derivatives: role in anticancer therapy","volume":"11","author":"Ouyang","year":"2021","journal-title":"Biomolecules"},{"issue":"13","key":"10.1016\/j.biopha.2025.118076_bib34","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2174\/1871520620999201124212840","article-title":"Chalcone scaffolds as anticancer drugs: a review on molecular insight in action of mechanisms and anticancer properties","volume":"21","author":"Shukla","year":"2021","journal-title":"Anticancer Agents Med Chem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118076_bib35","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/med.21698","article-title":"Chalcone hybrids as potential anticancer agents: current development, mechanism of action, and structure-activity relationship","volume":"40","author":"Gao","year":"2020","journal-title":"Med Res Rev."},{"issue":"21","key":"10.1016\/j.biopha.2025.118076_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111306","article-title":"Anticancer activity of natural and synthetic chalcones","volume":"22","author":"Constantinescu","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118076_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29020375","article-title":"CuAAC-based synthesis, copper-catalyzed aldehyde-forming hydrolytic fission and antiproliferative evaluation of novel ferrocenoylamino-substituted triazole-tethered quinine-chalcone hybrids","volume":"29","author":"Dembo","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118076_bib38","article-title":"Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence","volume":"11","author":"Salehi","year":"2020","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118076_bib39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bmcl.2013.11.034","article-title":"Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC)","volume":"24","author":"Jeong","year":"2014","journal-title":"Bioorg. Med Chem. Lett."},{"issue":"22","key":"10.1016\/j.biopha.2025.118076_bib40","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1021\/jm901278z","article-title":"Structure-activity relationship studies of chalcone leading to 3-hydroxy-4,3\u2032,4\u2032,5\u2032-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities","volume":"52","author":"Srinivasan","year":"2009","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118076_bib41","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2147\/OTT.S161109","article-title":"Role of the NF\u03baB-signaling pathway in cancer","volume":"11","author":"Xia","year":"2018","journal-title":"Onco Targets Ther."},{"issue":"12","key":"10.1016\/j.biopha.2025.118076_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210354","article-title":"Anticancer potential of natural chalcones: in vitro and in vivo evidence","volume":"24","author":"Michalkova","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118076_bib43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bmcl.2015.12.059","article-title":"Synthesis, structure and in vitro cytostatic activity of ferrocene-Cinchona hybrids","volume":"26","author":"Kocsis","year":"2016","journal-title":"Bioorg. Med Chem. Lett."},{"issue":"8","key":"10.1016\/j.biopha.2025.118076_bib44","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1039\/C7MT00183E","article-title":"Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel","volume":"9","author":"Podolski-Reni\u0107","year":"2017","journal-title":"Metallomics"},{"key":"10.1016\/j.biopha.2025.118076_bib45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejmech.2019.05.053","article-title":"Design, synthesis and biological evaluation of chalcones as reversers of P-glycoprotein-mediated multidrug resistance","volume":"180","author":"Yin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118076_bib46","first-page":"379","article-title":"MDR-reversal activity of chalcones","volume":"22","author":"Ivanova","year":"2008","journal-title":"Vivo"},{"key":"10.1016\/j.biopha.2025.118076_bib47","article-title":"Comparative study on the MDR reversal effects of selected chalcones","volume":"2011","author":"Ivanova","year":"2011","journal-title":"Int J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118076_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.101173","article-title":"Recent advances in chalcone-triazole hybrids as potential pharmacological agents","volume":"6","author":"Bhukal","year":"2023","journal-title":"Results Chem."},{"issue":"2","key":"10.1016\/j.biopha.2025.118076_bib49","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3892\/or.2012.2156","article-title":"Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation","volume":"29","author":"Wang","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2025.118076_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233993","article-title":"A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance","volume":"15","author":"Zahra","year":"2020","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.biopha.2025.118076_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.biopha.2025.118076_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030616","article-title":"Multidrug Resistance (MDR): a widespread phenomenon in pharmacological therapies","volume":"27","author":"Catalano","year":"2022","journal-title":"Molecules"},{"issue":"17","key":"10.1016\/j.biopha.2025.118076_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179451","article-title":"Battling chemoresistance in cancer: root causes and strategies to uproot them","volume":"22","author":"Ramos","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118076_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of multidrug resistance in cancer chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118076_bib55","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0020-7519(96)00152-X","article-title":"Quinoline antimalarials: mechanisms of action and resistance","volume":"27","author":"Foley","year":"1997","journal-title":"Int J. Parasitol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118076_bib56","doi-asserted-by":"crossref","DOI":"10.3171\/2014.12.FOCUS14748","article-title":"Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors","volume":"38","author":"Golden","year":"2015","journal-title":"Neurosurg. Focus"},{"issue":"22","key":"10.1016\/j.biopha.2025.118076_bib57","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1016\/j.bmc.2016.09.051","article-title":"Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones","volume":"24","author":"Jeon","year":"2016","journal-title":"Bioorg. Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118076_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bmc.2007.10.006","article-title":"Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein","volume":"16","author":"Liu","year":"2008","journal-title":"Bioorg. Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118076_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/mol.108.050492","article-title":"Inhibition of P-glycoprotein-mediated paclitaxel resistance by reversibly linked quinine homodimers","volume":"75","author":"Pires","year":"2009","journal-title":"Mol. Pharm."},{"issue":"17","key":"10.1016\/j.biopha.2025.118076_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175452","article-title":"Combination anticancer therapies using selected phytochemicals","volume":"27","author":"Talib","year":"2022","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.biopha.2025.118076_bib61","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1021\/acs.jmedchem.7b01457","article-title":"Inhibit or evade multidrug resistance p-glycoprotein in cancer treatment","volume":"61","author":"Waghray","year":"2018","journal-title":"J. Med Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118076_bib62","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/s41598-018-19325-x","article-title":"Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells","volume":"8","author":"Nanayakkara","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118076_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/DTI.S12519","article-title":"P-glycoprotein inhibition for optimal drug delivery","volume":"7","author":"Amin","year":"2013","journal-title":"Drug Target Insights"},{"issue":"5","key":"10.1016\/j.biopha.2025.118076_bib64","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5567","article-title":"Mechanism of multidrug resistance to chemotherapy mediated by P\u2011glycoprotein (Review).","volume":"63","author":"Tian","year":"2023","journal-title":"Int J. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118076_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.381","article-title":"A mechanism for overcoming P-glycoprotein-mediated drug resistance: novel combination therapy that releases stored doxorubicin from lysosomes via lysosomal permeabilization using Dp44mT or DpC","volume":"7","author":"Seebacher","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118076_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2014.11.002","article-title":"The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade","volume":"18","author":"Kathawala","year":"2015","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2025.118076_bib67","doi-asserted-by":"crossref","unstructured":"Siegel, R.L., A.N. Giaquinto, and A. Jemal, Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 2024. 74(1): p. 12-49.","DOI":"10.3322\/caac.21820"},{"key":"10.1016\/j.biopha.2025.118076_bib68","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.lungcan.2021.03.018","article-title":"Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non\u2013small cell lung cancer","volume":"155","author":"Furukawa","year":"2021","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2025.118076_bib69","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.21037\/tlcr-21-718","article-title":"Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?","volume":"10","author":"Kesireddy","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118076_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060334","article-title":"Screening compounds with a novel high-throughput ABCB1-mediated efflux assay identifies drugs with known therapeutic targets at risk for multidrug resistance interference","volume":"8","author":"Ansbro","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118076_bib71","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1179\/joc.2005.17.1.86","article-title":"Inhibition of P-glycoprotein function and expression by kaempferol and quercetin","volume":"17","author":"Limtrakul","year":"2005","journal-title":"J. Chemother."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:53:00Z","timestamp":1759002780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":71,"alternative-id":["S0753332225002707"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118076","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinine-chalcone hybrids as potent inhibitors of P-glycoprotein with apoptotic effects on EBC-1 cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118076"}}